Advanced search
Publication Cover
Journal of Intellectual & Developmental Disability Volume 33, 2008 - Issue 4
Submit an article Journal homepage
106
Views
18
CrossRef citations to date
0
Altmetric
Articles

The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS)

Johnny L. Matson Louisiana State University, Baton Rouge, USACorrespondence[email protected]
,
Jill C. Fodstad Louisiana State University, Baton Rouge, USA
&
Tessa T. Rivet Louisiana State University, Baton Rouge, USA
Pages 337-344 | Published online: 10 Jul 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Julie Hess, Johnny Matson, Daniene Neal, Sara Mahan, Jill Fodstad, Jay Bamburg & Jodie Holloway. (2010) A Comparison of Psychotropic Drug Side Effect Profiles in Adults Diagnosed With Intellectual Disabilities and Autism Spectrum Disorders. Journal of Mental Health Research in Intellectual Disabilities 3:2, pages 85-96.
Read now
Johnny L. Matson, Jill C. Fodstad, Tessa T. Rivet & Johannes Rojahn. (2009) Behavioral and Psychiatric Differences in Medication Side Effects in Adults With Severe Intellectual Disabilities. Journal of Mental Health Research in Intellectual Disabilities 2:4, pages 261-278.
Read now

Articles from other publishers (16)

Neasa Kelly, Andrew Kilmartin, Kevin Lannon, Caren Lee, Rory McLoughlin, Lara Mulvanny, Omnyiah Mohamed, Mairead Treacy, Karen Rossi & Juliette O’Connell. (2022) Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review. European Journal of Clinical Pharmacology 78:11, pages 1711-1725.
Crossref
Gerda Margaretha de Kuijper & Albert Willem Lenderink. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 4561 4581 .
Gerda Margaretha de Kuijper & Albert Willem Lenderink. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 21 .
Gerda M. de KuijperPieter J. Hoekstra. (2016) Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability. Journal of Clinical Psychopharmacology 36:5, pages 508-512.
Crossref
Frank Häßler. 2016. Polypharmazie in der Behandlung psychischer Erkrankungen. Polypharmazie in der Behandlung psychischer Erkrankungen 115 130 .
Frank Häβler, Johannes Thome & Olaf Reis. (2014) Polypharmacy in the treatment of subjects with intellectual disability. Journal of Neural Transmission 122:S1, pages 93-100.
Crossref
Anne Louise Tveter, Trine Lise Bakken, Jørgen G. Bramness & Jan Ivar Røssberg. (2014) Adjustment of the UKU Side Effect Rating Scale for adults with intellectual disabilities. A pilot study. Advances in Mental Health and Intellectual Disabilities 8:4, pages 260-267.
Crossref
Johnny L. Matson & Paige E. Cervantes. (2013) Current status of the Matson Evaluation of Drug Side Effects (MEDS). Research in Developmental Disabilities 34:5, pages 1849-1853.
Crossref
Frank Häßler & Johannes Thome. (2012) Intelligenzgeminderte Menschen besonders vulnerabel. NeuroTransmitter 23:9, pages 43-47.
Crossref
Paulette Marie Gillig & Richard Sanders. 2012. Psychiatry of Intellectual Disability. Psychiatry of Intellectual Disability 51 74 .
Johnny L. Matson, Brian Belva, Megan A. Hattier & Michael L. Matson. (2011) Pica in persons with developmental disabilities: Characteristics, diagnosis, and assessment. Research in Autism Spectrum Disorders 5:4, pages 1459-1464.
Crossref
Sara Mahan, Jodie Holloway, Jay W. Bamburg, Julie A. Hess, Jill C. Fodstad & Johnny L. Matson. (2010) An Examination of Psychotropic Medication Side Effects: Does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?. Research in Developmental Disabilities 31:6, pages 1561-1569.
Crossref
Johnny L. Matson & Sara Mahan. (2010) Antipsychotic drug side effects for persons with intellectual disability. Research in Developmental Disabilities 31:6, pages 1570-1576.
Crossref
Johnny L. Matson, Tessa T. Rivet & Jill C. Fodstad. (2009) Atypical Antipsychotic Adjustments and Side-Effects over Time in Adults with Intellectual Disability, Tardive Dyskinesia, and Akathisia. Journal of Developmental and Physical Disabilities 22:5, pages 447-461.
Crossref
Johnny L. Matson, Tessa T. Rivet & Jill C. Fodstad. (2008) Matson Evaluation of Drug Side-Effects (MEDS) Profiles of Selective Serotonin Reuptake Inhibitors (SSRI) in Adults with Intellectual Disability. Journal of Developmental and Physical Disabilities 21:1, pages 57-68.
Crossref
Johnny L. Matson, Tessa T. Rivet & Jill C. Fodstad. (2007) Matson Evaluation of Drug Side-effects (MEDS) Profiles in Adults with Intellectual Disability, Tardive Dyskinesia, and Akathisia. Journal of Developmental and Physical Disabilities 20:3, pages 283-295.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.